Provided by Tiger Trade Technology Pte. Ltd.

VanEck Healthcare TruSector ETF

29.22
0.0000
Volume:4
Turnover:117.22
Market Cap:584.45K
PE:- -
High:29.22
Open:29.22
Low:29.22
Close:29.22
52wk High:30.68
52wk Low:24.78
Shares:20.00K
Float Shares:20.00K
Volume Ratio:0.08
T/O Rate:0.02%
Dividend:0.08
Dividend Rate:0.29%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Circle Pharma Raises $92.5 Million in Series E Funding Led by Column Group

Reuters
·
1 hour ago

Twist Bioscience Corporation - to Provide Antibody Characterization Data Services for Lilly Tunelab

THOMSON REUTERS
·
1 hour ago

Circle Pharma: Financing Led by Column Group, Participation from Nextech Invest, Ra Capital Management, Strategic Investment from Eli Lilly and Co

THOMSON REUTERS
·
2 hours ago

Estee Lauder Cos. Cl a Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
16 hours ago

UnitedHealth Group Announces Earnings Release Date

THOMSON REUTERS
·
17 hours ago

Health Rounds: New Dye for MRI Exams Detects Lung Cancer Earlier

Reuters
·
18 hours ago

Thatch Raises $108 Million at $1 Billion Valuation

Reuters
·
20 hours ago

Thatch: Funding & Participation from the General Partnership, General Catalyst, Andreessen Horowitz, ADP Ventures, Eli Lilly & Others

THOMSON REUTERS
·
20 hours ago

U.S. Stocks on the MOVE-Forgent Power, Vera Bradley, Wells Fargo

Reuters
·
20 hours ago

LIVE Markets-from Ozempic Face to K-Beauty Factories: the Next Beauty Bet

Reuters
·
Yesterday

As Trump Backs Psychedelics Research, FDA Weighs Safety and Access Standards

Reuters
·
Yesterday

LIVE Markets-Autumn in New York: Factory Expansion Slows, Input Prices at Multi-Year Highs - Empire State

Reuters
·
Yesterday

Eli Lilly Stock (LLY) Gets New Buy Rating as Weight-Loss Drug Sales Accelerate

TIPRANKS
·
Yesterday

LIVE Markets-US Stock Indexes Swing Lower as Oil, Yields Jump

Reuters
·
Yesterday

Abbvie Exec Says Will Present Late-Stage Data for Blood Cancer Drug Etentamig at International Myeloma Society Meeting Later in September - Conf Call

THOMSON REUTERS
·
Yesterday

Abbvie Exec Says Existing Portfolio Provides 'Clear Line of Sight' to Very Strong Growth Well into Next Decade - Conf Call

THOMSON REUTERS
·
Yesterday

Abbvie Exec Says Apogee Fits 'Very Nicely' with Its Business Development Approach - Conf Call

THOMSON REUTERS
·
Yesterday

Abbvie Exec Says Plans to Start Enrolling Apogee's Zumilokibart This Year, Targets Launch in Early 2030 - Conf Call

THOMSON REUTERS
·
Yesterday

Abbvie Exec Says Tavapadon U.S. Launch Expected to Have 'Slower Burn' Due to Timing of Medicare Reimbursement - Conf Call

THOMSON REUTERS
·
Yesterday

Why One of the Last Eli Lilly Holdouts Just Upgraded the Stock to Buy

Dow Jones
·
Yesterday